Linda S. Jenckes

Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD.

Health Insurance Association of America, Inc. provided health care insurance and benefit plans. The company was headquartered in Washington, DC.

National Multiple Sclerosis Society is a not-for-profit organization that provides advocacy, fund raising, clinical services, client programs and up-to-date information to individuals with multiple sclerosis, their families and healthcare providers. The company was founded in 1946 by Sylvia Lawry and is headquartered in New York, NY.